SCHEMBL6861320

SCHEMBL6861320

c1cc(OCC2CO2)ccc1CCCc1ccc(OCC2CO2)cc1

nearest known ligand 0.61

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TDP1 Q9NUW8 1/20 0.61
ALDH1A1 P00352 4/20 0.57
TP53 P04637 3/20 0.57
TSHR P16473 3/20 0.57
MEN1 O00255 3/20 0.57
KMT2A Q03164 3/20 0.57
MAPT P10636 2/20 0.57
HPGD P15428 2/20 0.57
HIF1A Q16665 2/20 0.57
PKM P14618 2/20 0.57
CYP1A2 P05177 1/20 0.57
PPARG P37231 1/20 0.57
LMNA P02545 1/20 0.57
GAA P10253 1/20 0.57
CYP3A4 P08684 1/20 0.55
SMN1; SMN2 Q16637 1/20 0.55
MGLL Q99685 3/20 0.44
GLA P06280 1/20 0.43
HRH3 Q9Y5N1 1/20 0.42
NPC1 O15118 1/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28877996 0.95 TDP1 (0.59) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL3871705 0.92 TDP1 (0.66) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL150782 0.90 ALDH1A1 (0.55) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL11464933 0.89 ALDH1A1 (0.54) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL284522 0.89 ALDH1A1 (0.54) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL31303670 0.88 ALDH1A1 (0.66) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL31588804 0.88 ALDH1A1 (0.50) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL19909977 0.87 TDP1 (0.59) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL4615431 0.87 ALDH1A1 (0.53) TDP1ALDH1A1TP53TSHRMEN1
SCHEMBL284333 0.87 ALDH1A1 (0.53) TDP1ALDH1A1TP53TSHRMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 44 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20250206939-A1 CURABLE SULFONATED POLYMER COMPOSITIONS NOTARK CORPORATION (US) 2025-06-26 US claimed
CN-117247773-A Novel liquid-solid phase transition self-generating propping agent fracturing fluid system and preparation method thereof 中国石油天然气股份有限公司 2023-12-19 CN claimed
WO-2023062319-A1 TYRE WITH A TREAD COMPRISING REINFORCING ELEMENTS COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2023-04-20 WO claimed
US-20180256923-A1 SYSTEMS AND KITS FOR USER CUSTOMIZABLE COSMETICS, AND METHODS FOR THE PREPARATION OF USER CUSTOMIZED COSMETICS UNGVARSKY VANESSA (US) 2018-09-13 US claimed
US-20260088295-A1 DRY BINDER, AND ELECTRODE AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO LTD (KR) 2026-03-26 US disclosed
EP-4714997-A1 DRY BINDER, AND ELECTRODE AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME SAMSUNG SDI CO., LTD. (KR) 2026-03-25 EP disclosed
EP-4598755-A1 TYRE COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2025-08-13 EP disclosed
EP-4452923-A1 COMPOUND MATERIAL, PARTICULARLY COMPOSITE MATERIAL metron eging GmbH (DE) 2024-10-30 EP disclosed
EP-4452922-A1 COMPOSITE MATERIAL, METHOD OF PRODUCTION AND METHOD FOR THE ENERGY-EFFICIENT SEPARATION OF THE COMPOSITE metron eging GmbH (DE) 2024-10-30 EP disclosed
EP-4381003-A2 STRUCTURAL TRANSPARENT FIBER-MATRIX COMPOSITES AND PROCESS FOR PRODUCTION THEREOF Universität Stuttgart (DE) 2024-06-12 EP disclosed
WO-2024074787-A1 TYRE COMPAGNIE GENERALE DES ETABLISSEMENTS MICHELIN (FR) 2024-04-11 WO disclosed
CN-117247773-A Novel liquid-solid phase transition self-generating propping agent fracturing fluid system and preparation method thereof 中国石油天然气股份有限公司 2023-12-19 CN disclosed
US-5290879-A Chlorination in solvent mixture of chloroform and unsaturated compound; alcohol-free TOSOH CORPORATION (JP) 1994-03-01 US disclosed
US-5242996-A MODIFIED EPOXY RESINS HAVING ACETYLENICALLY UNSATURATED FUNCTIONS NIPPON PAINT CO., LTD. (JP) 1993-09-07 US disclosed
US-5212254-A Chlorination and chlorosulfonation of olefin polymers using phosgene, chlorination, sulfur dioxide and sulfuryl chloride TOSOH CORPORATION (JP) 1993-05-18 US disclosed
EP-0534465-A2 Curable resin composition NIPPON PAINT COMPANY LIMITED (JP) 1993-03-31 EP disclosed
EP-0458296-A2 Modified epoxy resins having acetylenically unsaturated functions NIPPON PAINT CO., LTD. (JP) 1991-11-27 EP disclosed
US-4939227-A Novel thermoplastic polymers SHELL OIL COMPANY (US) 1990-07-03 US disclosed
EP-0000769-B1 POLYMERS CONTAINING POLYALKYLPIPERIDINES AND USE THEREOF AS STABILIZERS SANKYO COMPANY LIMITED (JP) 1981-08-05 EP disclosed
US-4265803-A PHOTOSTABILITY AND HEAT RESISTANCE SANKYO COMPANY LIMITED (JP) 1981-05-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20260088295-A1 DRY BINDER, AND ELECTRODE AND RECHARGEABLE LITHIUM BATTERY INCLUDING THE SAME EPM2A, EPB41L2, PRRC2C TDP1 1459/4885ALDH1A1 3073/4885TP53 4259/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.